How Do Emerging Muscarinic Agonists Like KarXT Affect Anticholinergic Use?

Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

CME: Optimizing the Utility of Muscarinic Acetylcholine Receptor Activators in Clinical Practice

CME: Interpreting the Latest Clinical Data and Treatment Implications for Approved and Emerging Muscarinic Acetylcholine Receptor Activators in Schizophrenia

CME: Understanding Muscarinic Acetylcholine Receptor Activation as a Therapeutic Target in Schizophrenia

CME: Harnessing the Evolving Understanding of Schizophrenia to Address Treatment Challenges and Unmet Needs

Understanding the Cholinergic System

Assessing Anticholinergic Burden

Anticholinergic Misuse: Can These Medications Be Addictive?

Can Anticholinergic Medications Make Movement Disorders Worse?